GlassScriptPrepare for your visit
Manpreet Kanwar
Cardiovascular Disease · Mankato, MN · NPI 1063444669
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,959.38
in general payments reported to CMS, 2019-2025 · $1,231 in 2025
The $1,231 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Who reported paying
General payments only, top 6 by amount.
- Abbott Laboratories $1,408.75
- Amgen INC. $144.95
- Abiomed $143.27
- Novartis Pharmaceuticals Corporation $76.00
- Kiniksa Pharmaceuticals, LTD. $56.83
- Ge Healthcare $55.39
Drugs and devices associated with these payments
Thoratec Heartmate 3 Lvas Implant Kit Freestyle Libre 3 Repatha Leqvio Arcalyst Entresto Nexletol Wegovy
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Manpreet Kanwar listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/535825/manpreet-kanwar